“funded countries will receive enough doses to vaccinate up to 20 per cent of their population in the longer term.”
We are a funding country.
But, there’s also this:
“Even though self-financing participants can request for enough doses to vaccinate between 10-50% of their population, no country will receive enough doses to vaccinate more than 20% of its population until all countries in the financing group have been offered this amount. The only exception is those countries who have opted to receive fewer than 20%.”
Then there’s the sticking point that none of the vaccines have anything other than emergency approval so far, so anything done under emergency approval probably doesn’t count, with cries of “we’re vaccinating everyone in the Country so we can work out how effective the vaccine is”.
As the UK is aiming to produce around 0.95 billion doses of the AZ vaccine per year I can only see us being a major contributor to COVAX, plus Pune (where India makes billions of doses of various vaccines) is hoping to make around 2 billion doses of the AZ vaccine per year under licence, mainly for delivery to the 3rd World “funded” countries.
Another problem is the supply chain, and again the UK is working on a fix for RNA based vaccines… solid stable RNA vaccines at 4C anyone? – http://www.imperial.ac.uk/news/211413/vaccine-collaboration-could-overcome-cold-chain/